Outcome of AGM
Orchid Pharma Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company was held on September 28, 2016.In this regards, the Company has submitted to BSE a copy of Chairman's Speech.28-09-2016
28-09-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao & R Vijayalakshmi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE24-09-2016
Authorised KMPs to determine materiality of events/information
Orchid Pharma Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".15-09-2016
Sicom takes possession of Orchid
Orchid Pharma said that Sicom Ltd took possession of its property situated at Orchid Towers in Chennai on September 9 under the SARFAESI ACT, 2002. The company is in an advanced stage of discussion...14-09-2016
Updates
Orchid Pharma Ltd has informed BSE that ORCHID has received a Notice under Section 13(4)(a) of the SARFAESI ACT, 2002 from SICOM Limited, for the property situated at "Orchid Towers", 313, Valluvarkottam High Road, Nungambakkam, Chennai-600 034. Based on the said Notice, SICOM Limited has taken symbolic possession on September 09, 2016.However, the Company is in an advanced stage of discussions to raise resources, so that the loan availed from SICOM can be settled expeditiously.14-09-2016
AGM on Sept 28, 2016
Orchid Pharma Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company will be held on September 28, 2016.08-09-2016
Newspaper Advertisement of A G M notice, E-voting faciIfty & Book closure
Orchid Pharma Ltd has submitted to BSE a copy of Newspaper Advertisement of the Annual General Meeting notice, E-voting faciIfty and Book closure.08-09-2016
Fixes Book Closure for AGM
Orchid Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2016 to September 28, 2016 (both days inclusive) for the purpose of 23rd Annual General Meeting (AGM) of the Company to be held on September 28 , 2016.02-09-2016
Orchid Pharma net loss widens
Total income from operations stood at Rs 190.91 crore during this quarter, as against Rs 256.33 crore comparing to same quarter past year13-08-2016
Results Press Release for June 30, 2016
Orchid Pharma Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 201613-08-2016